Changes in salivary biomarkers with EMDR - Evidence for EMDR effectiveness in treatment of PTSD

AUTHORS

Tamaki Amano 1,2*, Kumiko Ikemura 3, Ikuko Amano 4 and Motomi Toichi 1,2
The Organization for Promoting Neurodevelopmental Disorder Research, Kyoto, Japan.
2 Graduate School of Medicine, Kyoto University, Kyoto, Japan.
3 Counseling Room, Okinawa, Japan.
4 Kobe Pharmaceutical University, Hyogo, Japan.
*Corresponding Author: Tamaki Amano, The Organization for Promoting Neurodevelopmental Disorder Research, Graduate School of Medicine, Kyoto University, Kyoto, Japan. E-mail: yiu60432@nifty.com

Introduction

Eye Movement Desensitization and Reprocessing (EMDR) is a form of psychotherapy that has been extensively studied and shown to be effective for the treatment of trauma. EMDR employs a set of standardized protocols that incorporates elements from many different forms of treatment [1]. Usually, to test the effectiveness of EMDR, a therapist uses a combination of two measures during EMDR sessions, the Subjective Units of Disturbance Scale (SUDS) and the Validity of Cognition (VoC) scale. The SUDS was developed by [2], although the version used in EMDR uses a scale of 0–10 instead of the original 100. The SUDS is a measure of current reactivity, with reduced reactivity indicating improvement. This widely used measure has documented validity and reliability, and is correlated with several physiological indices of distress. The VoC scale is an individualized measure of beliefs that was developed by [1]. The VoC uses a semantic differential scale and has documented validity and reliability [3]. The VoC itself has been used successfully in a number of trauma studies. However, both measures are subjective scales that measure clients’ feelings; they are not objective scales. Establishing the effectiveness of EMDR therapy will require considerable objective scientific research in many different fields.

Salivary and blood stress biomarkers are widely considered useful tools for measuring stress. Because saliva collection, unlike phlebotomy, is non-invasive and more acceptable to patients, using salivary biomarkers seems preferable for stress studies [4]. Previous studies of workplace stress, a major cause of anxiety, depression, burnout, and staff turnover­, have found that it is correlated with several salivary biomarkers [5]. However, research on psychological stress is complicated because the hypothalamic–pituitary–adrenal (HPA) endocrine system and the immune system interact [6]. The relationship between the nervous system and neuroendocrine responses to stress is mediated by hypothalamic corticotropin-releasing factor, and corticosteroids and catecholamines act as immunosuppressors [7]. Therefore, the choice of salivary biomarker depends on the type of stress being studied. For example, chronic stress is associated with activation of the HPA axis (measured by salivary cortisol (Crti.)) and suppression of immune function (measured by salivary immunoglobulin A (s-IgA)) [8]. Acute stress is associated with activation of the sympathoadrenal system, which is reflected by changes in salivary α-amylase and chromogranin-A (CgA). These are glycoproteins that are co-released with catecholamines (epinephrine, norepinephrine, and dopamine) [9]. The fundamental issue in the psychobiology of a traumatic experiences leading to PTSD is how circulating stress hormones are implicated in the pathogenesis of PTSD [10]. According to classical studies of PTSD (animal experiments) looking at Crti. levels, a cascade of central stress reactions may lead to intrusive recollection of events, avoidance of reminders of events, and symptoms of hyperarousal [11]. In previous EMDR studies, Crti. levels were examined before and after EMDR psychotherapy [12]. However, we considered that the relationship between the sympathoadrenal and immune systems should be examined in PTSD, in addition to the Crti. levels as a measure of HPA axis activity.

In this study, we examined Crti. as the HPA axis hormone indicator, s-IgA as the immune function indicator, and CgA as the sympathoadrenal system indicator in saliva, during EMDR sessions over time.

Materials and Methods

1. Ethics statement

These experimental procedures were approved by the local ethics committee of the Organization for Promoting Neurodevelopmental Disorder Research, and were carried out in accordance with the principles of the 1964 Declaration of Helsinki. The measures and procedures were explained to all subjects by the examiner, and all agreed and gave written informed consent before the start of the experiment.

2. Subjects

The subjects were four PTSD clients who were treated with standard EMDR therapy. All individuals were adult women (28–37 years old), non-smokers, right handed, and had no neurodevelopmental disorders. One client had Graves’ disease.

Subjects’ saliva was collected at each session. As each biomarker had its own daily variability (circadian rhythm), salivary samples were collected at a fixed time each day. All sessions were conducted in the morning. 

Subject profiles

Case 1: Subject A (37 years old, female)

Subject A was the daughter of a lawyer and had a happy life. Her mother had a hysterical personality and often interfered excessively with A’s life. She complained and ordered A to do her best in everything. Eventually the subject became submissive. She was a good and shy student, but chubby. She was often teased by boys, so she started to diet. She became very anorexic and was hospitalized. Her mother sometimes criticized A for neglecting her studies. Consequently, A lost confidence in herself. When she failed her law examination, she tried to commit suicide. She tried several jobs, but could not continue because she had lost her confidence.

Case 2: Subject B (30 years old, female)

Subject B was a policewoman. One day, during working hours, her 22-year-old male colleague killed himself suddenly with his own gun. When B noticed he was missing, she and her colleagues looked for him. They found his body in the forest with a gunshot wound in his forehead. She was the first person to find him, and she was afraid when she saw the blood and the gunshot wound on his face. Because B was his boss, she felt responsible for his suicide. She regretted not having noticed his problems. As a result, she had nightmares of a gun pointing at her forehead just before she was shot. She could not sleep in the dark, so she slept with her room light and TV on. She could not go to work because she was traumatized by the sight of policemen carrying guns. She was absent from work for a year and a half.

Case 3: Subject C (28 years old, female)

Subject C was an excellent student and the captain of a sports team through high school. However, at the university, she could not keep up with her classmates. She finally graduated with a friend’s help. She then got a job, but she was unable to do her job well. Whenever she went to work, she got headaches and vomited. After an absence of a year and a half, she decided to stop working because she lacked confidence in herself. A year later, she got another job, but she could not continue it because her colleagues were unkind and said harsh things to her. Her headache and vomiting recurred, so she took a leave of absence once again. When she recalled these memories, she suddenly became emotional and burst into tears.

Case 4: Subject D (41 years old, female)

This client had experienced many deaths of people close to her. When D was 8 years old, her grandfather committed suicide on New Year’s Eve. When she was 9 and 10 years old, her grandmother and uncle, respectively, committed suicide. Following this, every New Year’s Eve, she would become sick.

Her first panic attack occurred in a car when she was in junior high school. She had no subsequent symptoms for a while, but when she was pregnant with her first child, her panic symptoms reappeared while she was driving. For 10 years, she was treated with psychosomatic medicine, and her condition improved. However, she suddenly had a panic attack again when she took her child to the hospital. Thereafter, every time she heard an ambulance siren, she had a panic attack, so she could not go out alone.

3. Subjective Scales

  1. The Impact of Event Scale-Revised (IES-R) [13] was used during the pre-treatment assessment session and at the last EMDR session.

 IES-R is a 22-item self-report measure that assesses subjective distress caused by traumatic events. Items are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). The IES-R yields a total score ranging from 0 to 88. Scores for the Intrusion, Avoidance, and Hyperarousal subscales can also be calculated. In general, the IES-R is not used to diagnose PTSD. However, the cutoff score for a preliminary diagnosis of PTSD is 24 [14].

  1. The Subjective Units of Disturbance Scale (SUDS) was administered during every session.

 SUDS was used to measure current reactivity in each EMDR session.

4. salivery Biomarkers

 Crti., s-IgA, and CgA in saliva were assayed in every session as objective measures. The salivary samples were collected four times during each EMDR session. The first sample was collected before the session (before session). The second sample was collected when the therapist administered the SUDS for before EMDR treatment (pre-EMDR). The third sample was collected at the end of the EMDR treatment (post-EMDR). The fourth sample was collected after the session (after session). The full treatment program took several months. 

1.Data development process during full EMDR treatment

As CgA is immediately co-released with catecholamines, the second sample was assayed as data indicating the highest state of arousal. Crti. is secreted into the saliva at a delay of about 30 minutes [15], so the fourth sample was considered to measure the highest arousal. Finally, as s-IgA does not change greatly, the first sample was considered to provide immune data for the day.

2. Data development process during one EMDR session

CgA data are considered to reflect the emotional change process during an EMDR session, as CgA reflects immediate psychic stress levels. CgA levels reflected the amount of catecholamines. However, Crti. and s-IgA were not used to assess changes during individual sessions because they do not change quickly with psychological stress. However, because subject D had Graves’ disease, her CgA data may have been complicated by the influence of thyroid hormones.

Saliva collection

Saliva samples were collected using Salivette® (Sarstedt Co., Ltd., Numbrecht, Germany). Saliva was obtained from cotton that subjects had bitten for 2 min by centrifuging at 3,000 rpm for 5 min. Salivary CgA, Crti, and s-IgA levels were determined by ELISA.

The half-life of these stress biomarkers should also be considered; that of salivary Crti. is about an hour, that of salivary CgA is 15–20 min, and that of salivary s-IgA is 3–5 days. Each sample was stored in an ice box immediately and then stored at -72℃ until the assay.

ELISA assay

To quantify the CgA, Crti, and s-IgA levels, saliva samples were collected and assayed using competitive ELISA kits according to the manufacturers’ protocols. CgA level was determined using a Human Chromogranin A EIA Kit® (Cosmo Bio, Japan); Crti. level was determined using Cortisol, EIA Kit, and DetectX® (Ann Arbor assays, Michigan, USA); and s-IgA level was determined using salivary secretory IgA® (Salimetrics, CA, USA).

Results

1. IES-R

The subjects’ IES-R scores are shown in Table 1, which details the total scores and the scores for the Intrusion, Avoidance, and Hyperarousal subscales. However, subject C did not complete this assessment. In subjects A, B and D, the total scores were >25 (the cutoff point was 24), indicating that the three subjects exhibited PTSD symptoms. At the last EMDR session for subjects A, B, and D all scored below the cutoff point, indicating that their symptoms no longer met the criterion for PTSD. However, subject B’s score was higher during the fifth session than previously, so she continued EMDR sessions for another month. We did not collect saliva samples during the additional sessions.

 

 

Table 1: Scores shown are from the pre-treatment assessment session and the last EMDR sessions. Subject C did not complete this measure.

Fig. 1 shows the PTSD types by subscale. Subject A experienced more intrusion than did subjects B and D. Subject B exhibited more hyperarousal than did A and D. Subjects B and D avoided traumatic memories more than subject A did.

Figure 1:  Graphs of the IES-R subscales for Subject A, B, D at the pre-EMDR and at the post-EMDR session.

2. SUDS score

During the EMDR sessions, the SUDS was used to assess changes in clients’ cognitions. Table 2 shows the subjects’ SUDS scores at each session. In all sessions, the subjects’ SUDS scores decreased enough for them to recover positive cognition. The reductions in SUDS scores indicate the success of each EMDR session.

 

Table 2: Changes in SUDS scores across sessions

3. Salivary biomarkers

1) Changes over the full course of EMDR treatment 

 (1) CgA

Changes in salivary CgA levels are shown in Fig. 2. All levels tended to decrease gradually during the course of treatment.

Figure 2: Changes in CgA levels during EMDR treatment.

(2) Crti.

Changes in salivary Crti. levels are shown in Fig. 3. All levels tended to decrease gradually during treatment.

Figure 3: Changes in Crti. levels during EMDR treatment.

(3) s-IgA

Changes in salivary s-IgA levels are shown in Fig. 4. Little change was observed over the course of treatment.

Figure 4: Changes in s-IgA levels during EMDR treatment

 

2) Changes during each individual EMDR session

(1) CgA

Changes in the salivary CgA level for each session are shown in Fig. 5. In all subjects, the average CgA level before sessions was low, but it gradually increased during the session. The average level after sessions decreased in all except subject D. As subject D had Graves’ disease, it is possible that her CgA data were complicated by thyroid hormones.

Figure 5: Changes in CgA average levels in an individual session.

(2) Crti.

Changes in the salivary Crti. levels are shown in Fig. 6. All levels tended to increase during EMDR. This indicates that each EMDR session was more stressful than the pre-treatment period was. This is likely because the subjects had to recall traumatic memories during the EMDR session.

 

Figure 6: Average changes in Crti. levels in an individual session.

(3) s-IgA

Changes in the salivary s-IgA levels are shown in Fig. 7. There was little change for all subjects, as the immune system does not tend to respond quickly.

Figure 7: Average changes in s-IgA levels in an individual session.

Discussion 

The data showing changes in IES-R and SUDS suggest that EMDR is effective (Tables 1, 2). They show that the EMDR therapy resulted in a decrease in PTSD symptoms and in negative cognitions. Using subjective indicators, the results indicate that standard EMDR successfully processed the subjects’ trauma.

First, according to objective biomarkers, changes over the full course of EMDR treatment indicated that EMDR therapy was effective. The Crti. levels assayed in the fourth sample and the CgA levels in the second sample were the same as would be predicted under normal physiological conditions because the reflection of Crti. was 30 minutes delayed. CgA and Crti. data (Figs. 2, 3) indicated that EMDR was effective for treatment of PTSD because both levels tended to decrease.

Specifically, in subject A, the CgA and Crti. levels were decreased after the third EMDR session, indicating that EMDR reduced arousal in response to traumatic memories after the third session. In subject B, both CgA and Crti. levels were low during the first session, and both increased gradually after the second session. Both then decreased after the fourth session. As subject B was afraid to recall traumatic memories, she avoided them. In the first session, she was fearful, and her SUDS score dropped from 10 to 8 (Table 2). Her IES-R subscore showed that her avoidance and hyperarousal symptoms were greater than her intrusive ones (see Fig. 1). She was bothered by nightmares and afraid of guns. With EMDR, her fear was focused step by step, and she could finally recall her memory without fear. After her third session, the EMDR effect increased, and her SUDS score decreased from 10 to 3.5 (Table 2). However, her PTSD symptoms remained in the fifth session (her IES-R score was 26). Hence, EMDR was continued for several more sessions, and in the ninth session, her IES-R score was 18 points. Since we could not collect her saliva in the additional sessions, the changes in biomarkers shown here correspond to a point mid-way through her full treatment. After three sessions, both subjects C and D had SUDS scores low enough to indicate that they had recovered their positive cognition. Their CgA and Crti. levels also reflected the effectiveness of EMDR.

As measured by s-IgA levels, there was little change in subjects’ immune systems during EMDR treatment. This suggests that the immune system recovers from trauma slowly. Longer-term research, for several months or years, will be necessary to elucidate this process. 

Furthermore, changes measured during each EMDR session also showed interesting results. The CgA results can be classified into two types: In the first type, represented by subjects A and D, pre-EMDR levels were higher than post-EMDR levels; in the second type, represented by subjects B and C, post-EMDR levels were higher than pre-EMDR levels. Clinically, it is easier to focus on traumatic memories with the first than with the second type. Furthermore, the second type suffers more during treatment because it is difficult to focus on the traumatic memories. We considered that these treatment differences were reflected in the IES-R subscores. The Crti. results showed that EMDR therapy was naturally stressful because it was difficult for subjects to recall their traumatic memories (Fig. 6). During EMDR sessions, if a client avoided recalling traumatic memories, it would be impossible to eliminate the conditioned response between the traumatic memories and emotion. In a previous publication, we wrote, ‘one possible mechanism underpinning the main therapeutic stage of EMDR would be as follows: while traumatic memory is activated, induced EMs block the over-representation of the traumatic memory through a forced attentional shift, while they simultaneously ameliorate the conditioned fear by stimulating the AMG’[16]. The present Crti. results indicate success in focusing on traumatic memories, and the CgA results highlight the psychological stress involved in an EMDR session. At first, CgA levels increased gradually as attention was focused on the traumatic memories, and then the stress level was decreased by desensitization through processing traumatic memories during EMDR treatment. With respect to the s-IgA results, as there was little change during EMDR sessions, it appears that the immune system recovers from PTSD slowly (Fig. 7).

Thus, salivary biomarkers were useful in demonstrating the effectiveness of EMDR treatment for PTSD. The use of several salivary biomarkers has recently become a valuable research tool. The current study successfully shows that changes salivary biomarkers provide physiological evidence of therapeutic mechanism of EMDR in different types of PTSD.

Limitations

This study has several limitations. First, to obtain the data on salivary biomarkers, saliva must be collected at a fixed time because of changes due to the circadian rhythm[17,18]. So, in order to collect saliva in the morning, we were not able to honor all of the clients’ needs in scheduling EMDR sessions. Second, we only tested four subjects. We need to examine more subjects to confirm the present findings, and data should be analyzed using statistical techniques

References

  1. Shapiro, F. (1989). Eye movement desensitization: a new treatment for post-traumatic stress disorder. Journal of Behavior Therapy and Experimental Psychiatry, 20, 211–217.
  2. Wolpe, J. (1958). Psychotherapy by Reciprocal Inhibition, California: Stanford University Press, 53-62.
  3. Gordon J. Emmerson and Margery A. Neely (2008).Two Adaptable, Valid, and Reliable Data-Collection Measures: Goal Attainment Scaling and the Semantic Differentialhttps://doi.org/10.1177/0011000088162007
  4. Shimada, M., Takahashi, K., Ohkawa, T., Segawa, M. and Higurashi, M. (1995). Determination of salivary, cortisol by ELISA and its application to the assessment of the circadian rhythm in children. Hormone Research, 44, 213-2I7.
  5. Koh, D. S., and  Koh, G. C. (2006). The use of salivary biomarkers in occupational and environmental medicine. Occupational and Environmental Medicine, 64, 202–210. doi: 10.1136/oem..026567
  6. Chrousos, G. P. and Gold, P. W. (1992). The concepts of stress and stress system disorders. Journal of the American Medical Association, 267, 1244-1252.
  7. Hellhammer, D. H., Wüst, S. and  Kudielka, B. M. (2009). Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology, 34(2), 163-171. https://doi.org/10.1016/j.psyneuen.2008.10.026
  8. Tsujita, S., & Morimoto, K. (1999). Secretory IgA in saliva can be a useful stress marker. Environmental Health and Preventive Medicine Environ Health Prev Med, 4, 1-8. doi: 10.1007/BF02931243
  9. Black, P. H. (1994). Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain. Antimicrobial Agents and Chemotherapy, 38 (1), 740-793.
  10. Heim, C., Newport, D. J., Bonsall, R., Miller, A. H. and Nemeroff C. B. (2001). Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse: the role of comorbid depression. American Journal of Psychiatry, 158, 575–581. [PubMed: 11282691]
  11. Griffin M. G., Nishith, P., Resick, P. A., and Yehuda, R. (1997). Integrating objective indicators of treatment outcome in posttraumatic stress disorder. Annals of the New York Academy of Science, 821, 388–409.
  12. Heber. R., Kellner, M. and Yehuda, R. (2002). Salivary cortisol levels and the cortisol response to dexamethasone before and after EMDR: A case report. Journal of Clinical Psychology, 58, 1521–1530. [PubMed: 12455019]
  13. Kellner, M., Baker, D. G, and Yehuda, R. (1997). Salivary cortisol in Operation Desert Storm returnees. Biological Psychiatry, 42: 849–850. [PubMed: 9347135]. Doi: http://dx.doi.org/10.1016/S0006-3223(97)00304-1
  14. Weiss, D. & Marmar, C. (1997). The Impact of Event Scale-Revised. In J. Wilson & T. Keane (Eds), Assessing psychological trauma and PTSD. New York: Guildford
  15. Morina, N., Ehring, T. and  Priebe, S. (2013). Diagnostic utility of the Impact of Event Scale–Revised in two samples of survivors of war. PLoS ONE, 8(12), e83916. doi:10.1371/journal.pone.0083916.
  16. Kirschbaum, C. and Hellhammer, D. H. (1994). Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology, 19, 313-333.
  17. Amano, T. & Toichi, M. (2016). Possible neural mechanisms of psychotherapy for trauma-related symptoms: cerebral responses to the neuropsychological treatment of post-traumatic stress disorder model individuals. Scientific Reports (Nature Publishing Group, a division of Macmillan Publishers Ltd). Manuscript ID: SREP-15-30446C. DOI: 10.1038/srep34610
  18. Brigitte, M., Kudielka, D. H., & Wüst, S. (2009). Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology, 34(1), 2-18. https://doi.org/10.1016/j.psyneuen.2008.10.004